Microglia activation and neuroinflammation represent a third key determinant in the aetiopathogenesis of Alzheimer’s disease and in its progression (Heneka et al., 2015; Mhatre et al., 2015; Calsolaro and Edison, 2016), independently or synergistically with tau and amyloid pathology. Here, MAPT is linked to Alzheimer disease.